R. Matt Gladden

1.2k total citations · 4 hit papers
12 papers, 821 citations indexed

About

R. Matt Gladden is a scholar working on Public Health, Environmental and Occupational Health, Emergency Medicine and Toxicology. According to data from OpenAlex, R. Matt Gladden has authored 12 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 9 papers in Emergency Medicine and 6 papers in Toxicology. Recurrent topics in R. Matt Gladden's work include Opioid Use Disorder Treatment (11 papers), Poisoning and overdose treatments (8 papers) and Forensic Toxicology and Drug Analysis (6 papers). R. Matt Gladden is often cited by papers focused on Opioid Use Disorder Treatment (11 papers), Poisoning and overdose treatments (8 papers) and Forensic Toxicology and Drug Analysis (6 papers). R. Matt Gladden collaborates with scholars based in United States. R. Matt Gladden's co-authors include Julie O’Donnell, Christine L. Mattson, Nicole L. Davis, Puja Seth, Lauren J. Tanz, Stephen V. Liu, Mbabazi Kariisa, Bruce A. Goldberger, Kimberly D. Miller and Dita Broz and has published in prestigious journals such as Addiction, American Journal of Transplantation and MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

R. Matt Gladden

12 papers receiving 781 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine — 25 States, July–December 2017 to January–June 2018

2019 229 citations R. Matt Gladden, Julie O’Donnell et al. MMWR Morbidity and Mortality Weekly Report profile →
Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants — 24 States and the District of Columbia, January–June 2019

2020 175 citations Julie O’Donnell, R. Matt Gladden et al. MMWR Morbidity and Mortality Weekly Report profile →
Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020

2021 151 citations Julie O’Donnell, Lauren J. Tanz et al. MMWR Morbidity and Mortality Weekly Report profile →
Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022

2024 50 citations Lauren J. Tanz, R. Matt Gladden et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by R. Matt Gladden

Since Specialization

Citations

This map shows the geographic impact of R. Matt Gladden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Matt Gladden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Matt Gladden more than expected).

Fields of papers citing papers by R. Matt Gladden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Matt Gladden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Matt Gladden. The network helps show where R. Matt Gladden may publish in the future.

Co-authorship network of co-authors of R. Matt Gladden

This figure shows the co-authorship network connecting the top 25 collaborators of R. Matt Gladden. A scholar is included among the top collaborators of R. Matt Gladden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Matt Gladden. R. Matt Gladden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Drug Overdose Deaths Involving Stimulants ― United States, January 2018–June 2024 2025 ·MMWR Morbidity and Mortality Weekly Report ·Lauren J. Tanz, Kimberly D. Miller, (unknown), R. Matt Gladden, Alice Asher, Grant Baldwin, (unknown), Julie O’Donnell	1
2	Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths — United States, 2021–2024 2024 ·MMWR Morbidity and Mortality Weekly Report ·Lauren J. Tanz, Andrea Stewart, R. Matt Gladden, Jean Y. Ko, (unknown), Julie O’Donnell	14
3	Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022 breakdown → 2024 ·MMWR Morbidity and Mortality Weekly Report ·Lauren J. Tanz, R. Matt Gladden, (unknown), Kimberly D. Miller, Dita Broz, (unknown), Julie O’Donnell	50
4	Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses — Eight Syringe Services Programs, Maryland, November 2021–August 2022 2023 ·MMWR Morbidity and Mortality Weekly Report ·(unknown), Edward Sisco, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), R. Matt Gladden	36
5	Notes From the Field: Overdose Deaths Involving Eutylone (Psychoactive Bath Salts) — United States, 2020 2022 ·MMWR Morbidity and Mortality Weekly Report ·R. Matt Gladden, (unknown), Julie O’Donnell, Bruce A. Goldberger	9
6	Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018–December 2019 2021 ·Addiction ·Julie O’Donnell, R. Matt Gladden, Mbabazi Kariisa, Christine L. Mattson	23
7	Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines — 38 States and the District of Columbia, 2019–2020 2021 ·MMWR Morbidity and Mortality Weekly Report ·Stephen V. Liu, Julie O’Donnell, R. Matt Gladden, (unknown), (unknown)	69
8	Trends in nonfatal and fatal overdoses involving benzodiazepines—38 states and the District of Columbia, 2019–2020 2021 ·American Journal of Transplantation ·Stephen V. Liu, Julie O’Donnell, R. Matt Gladden, (unknown), (unknown)	16
9	Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020 breakdown → 2021 ·MMWR Morbidity and Mortality Weekly Report ·Julie O’Donnell, Lauren J. Tanz, R. Matt Gladden, Nicole L. Davis, (unknown)	151
10	Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected — 28 States and the District of Columbia, July 2016–December 2018 2020 ·MMWR Morbidity and Mortality Weekly Report ·Julie O’Donnell, R. Matt Gladden, Bruce A. Goldberger, Christine L. Mattson, Mbabazi Kariisa	48
11	Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants — 24 States and the District of Columbia, January–June 2019 breakdown → 2020 ·MMWR Morbidity and Mortality Weekly Report ·Julie O’Donnell, R. Matt Gladden, Christine L. Mattson, (unknown), Nicole L. Davis	175
12	Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine — 25 States, July–December 2017 to January–June 2018 breakdown → 2019 ·MMWR Morbidity and Mortality Weekly Report ·R. Matt Gladden, Julie O’Donnell, Christine L. Mattson, Puja Seth	229

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact